Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Core One Labs Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Stranius75on May 31, 2018 7:30pm
52 Views
Post# 28108678

RE:Spoke to HR at LDS!!! Cannistrips will be for sale starting

RE:Spoke to HR at LDS!!! Cannistrips will be for sale startingTake a hike twitty bird. More like you should do some DD .....
TwitterFeedLive wrote: Less than 1 months time and Cannisptrips will be availble for purchase on mass scale in the california market/online. Very nice gentleman will answer the phone, if you decide you want to clarify information.  They are looking to prioitize the "california market before spreading out, as they will be in full production, expecting 50 plus million in revenue by years end".  Canada is not an immediate play for them, "unless an LP decides to pick them up".  eom. 

I SAY FANTASTIC, DO YOUR DD and REINFORCE YOUR INVESTMENT.



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities